| Literature DB >> 20634237 |
Alice V Lin1, Valley Stewart2,1.
Abstract
NarL and NarP are paralogous response regulators that control anaerobic gene expression in response to the favoured electron acceptors nitrate and nitrite. Their DNA-binding carboxyl termini are in the widespread GerE-LuxR-FixJ subfamily of tetrahelical helix-turn-helix domains. Previous biochemical and crystallographic studies with NarL suggest that dimerization and DNA binding by the carboxyl-terminal domain (CTD) is inhibited by the unphosphorylated amino-terminal receiver domain. We report here that NarL-CTD and NarP-CTD, liberated from their receiver domains, activated transcription in vivo from the class II napF and yeaR operon control regions, but failed to activate from the class I narG and fdnG operon control regions. Alanine substitutions were made to examine requirements for residues in the NarL DNA recognition helix. Substitutions for Val-189 and Arg-192 blocked DNA binding as assayed both in vivo and in vitro, whereas substitution for Arg-188 had a strong effect only in vivo. Similar results were obtained with the corresponding residues in NarP. Finally, Ala substitutions identified residues within the NarL CTD as important for transcription activation. Overall, results are congruent with those obtained for other GerE-family members, including GerE, TraR, LuxR and FixJ.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20634237 PMCID: PMC3068693 DOI: 10.1099/mic.0.040469-0
Source DB: PubMed Journal: Microbiology (Reading) ISSN: 1350-0872 Impact factor: 2.777
Fig. 1.NarL and TraR CTD sequences. The four α-helices include the central HTH element. Results for TraR are from Qin and White & Winans (2005). Boxed residues indicate phenotypes for Ala substitutions: black, PC; white, functional; bold type and outline, deficient. Grey-shaded boxes indicate positions where substitution with residues other than Ala results in the PC phenotype. Residues in bold type are implicated in direct recognition of DNA (Maris ; White & Winans, 2007). The TraR-CTD sequence shown is from plasmid pTiR10 (White & Winans, 2005); the TraR-CTD sequence from plasmid pTiC58 differs at three positions (Val-168, Met-189 and Val-194) (Qin ).
Fig. 2.Control regions used in this study. The scale is in nucleotides. Nar 7–2–7 heptamer pairs are depicted as black inverted arrows, whereas sites for other proteins are depicted as white boxes or inverted arrows. Numbers show positions of binding-site centres relative to the transcription initiation point.
Strains and plasmids used in this study
| BW25113 | ||
| VJS632 | F− | |
| VJS676 | As VJS632 but Δ( | |
| VJS8364 | As VJS632 but Δ | |
| VJS2197 | ||
| VJS4147 | ||
| VJS6317 | ||
| VJS6906 | ||
| VJS6990 | ||
| VJS7449 | ||
| VJS7489 | ||
| VJS7623 | This work | |
| VJS9284 | This work | |
| VJS9719 | This work | |
| VJS10030 | This work | |
| VJS10054 | This work | |
| VJS10247 | This work | |
| VJS10248 | This work | |
| VJS10258 | This work | |
| VJS10461 | This work | |
| VJS10649 | This work | |
| VJS10665 | This work | |
| VJS9565 | ||
| VJS10983 | This work | |
| VJS11159 | This work | |
| LITMUS 39 | Apr; | New England Biolabs |
| pACYC184 | Cmr, Tcr; | |
| pAH69 | Apr; | |
| pAH123 | Apr; | |
| pAH144 | Smr; | |
| pAH153 | Gmr; | |
| pCP20 | Apr, Cmr; Flp+; | |
| pKD13 | Apr, Kmr; | |
| pKD46 | Apr; Red+; | |
| pQE30 | Apr; | Qiagen |
| pQE32 | Apr; | Qiagen |
| pSU18 | Cmr; | |
| pSU19 | Cmr; | |
| pVJS2288 | Apr; His6- | |
| pVJS2294 | Apr; His6- | |
| pVJS4095 | Cmr; | This work |
| pVJS4098 | Cmr; | This work |
| pVJS4505 | Cmr; | This work |
| pVJS4506 | Cmr; | This work |
| pVJS5259 | Apr; His6- | This work |
| pVJS5265 | Apr; His6- | This work |
DNA-binding affinities
| His6-NarL† | 1.0±0.05 | 0.3±0.1 | 3.2±0.08 |
| His6-NarL-CTD | 9±2 | 0.1±0.06 | 2.3±0.5 |
| His6-NarP-CTD | 4±1 | 0.2±0.06 | 6±1 |
| His6-NarP-CTD (K186A) | 1.0±0.2 | –‡ | – |
| His6-NarP-CTD (V187A) | >30 | – | – |
| His6-NarP-CTD (R190A) | >30 | – | – |
*EMSA with binding site amplified from the indicated O1-substitution constructs.
†Reaction performed with 100 mM acetyl phosphate.
‡–, Not determined.
Effects of recognition helix alterations on the NarL–DNA interaction
| None | – | 0 | 0 | 0 |
| Wild-type | 0.9±0.2 | 100 | 100 | 100 |
| K188A | 1.8±0.7 | 26 | 3.4 | 15 |
| V189A | 11±2 | 46 | 58 | 57 |
| K192A | >30 | <0.1 | 17 | 21 |
*Indicated His6-NarL-CTD protein or narL allele integrated at att Φ80.
†EMSA with binding site amplified from the indicated O1-substitution construct.
‡Percentage repression or activation relative to wild-type value during growth with nitrate (Zhang ).
§VJS10054 [O1-nirB (−74/−74)], VJS10030 (O1-nirB) and VJS10665 (O1-napF).
Transcription control by NarL-CTD and NarP-CTD
| pACYC184 | None | 0 | 0 | 0 |
| pVJS4095 | NarL | 100 | 100 | 100 |
| pVJS4505 | NarL-CTD | 66 | 98 | 21 |
| pVJS4098 | NarP | 99 | 155 | 76 |
| pVJS4506 | NarP-CTD | 63 | 154 | 20 |
*Percentage repression or activation relative to wild-type value during growth with nitrate (Zhang ).
†VJS9284 [λΦ(napF)], VJS10983 [λΦ(yeaR–lacZ)] and VJS9719 (O1-napF).
Fig. 3.X-ray model of a NarL-CTD dimer in complex with its DNA-binding site from the nirB operon control region; from Maris . The two protomers are coloured blue and gold, and the two DNA strands are shaded light and dark grey. Residues are highlighted according to their phenotype: PC, red (Arg-178, Arg-179, Asp-181); functional, green (Asp-162, Leu-166, Gln-169, Met-175); deficient, violet (Leu-171, Lys-199); DNA-binding, orange (Lys-188, Val-189, Lys-192).
Phenotypes of NarL missense mutants
| None | 0 | 0 | 0 | 0 | 0 | 0 |
| Wild-type | 100 | 100 | 100 | 100 | 100 | 100 |
| L171A | 85 | 68 | 1.2 | 24 | 48 | 56 |
| K199A | 94 | 86 | 1.0 | 26 | 40 | 43 |
| D162A | 96 | 97 | 70 | 52 | 52 | 86 |
| M175A | 100 | 101 | 86 | 92 | 103 | 185 |
| Q169A | 99 | 102 | 98 | 96 | 57 | 313 |
| L166A | 98 | 99 | 119 | 85 | 70 | 242 |
| R178A | 101 | 99 | 18 | 33 | 86 | 86 |
| R179A | 100 | 101 | 61 | 52 | 226 | 100 |
| D181A | 98 | 102 | 52 | 41 | 146 | 93 |
| R178A+R179A | 101 | 105 | <0.1 | 5.5 | 8 | 28 |
| R179A+D181A | 101 | 81 | 39 | 14 | 20 | 31 |
*Indicated allele integrated at att Φ80.
†Percentage repression or activation relative to wild-type value during growth with nitrate (Zhang ).
‡VJS10461 (O1-nrfA), VJS9719 (O1-napF), VJS10649 [λΦ(napF–lacZ)], VJS10247 [λΦ(napF)], VJS10258 [λΦ(narG–lacZ)] and VJS10248 [λΦ(fdnG–lacZ)].